Share Price and Basic Stock Data
Last Updated: October 15, 2025, 6:14 pm
| PEG Ratio | 0.42 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Frontline Corporation Ltd, operating in the transport sector, reported a current share price of ₹42.4 and a market capitalization of ₹21.2 Cr. The company has shown a consistent upward trend in sales, rising from ₹72 Cr in FY 2022 to ₹77 Cr in FY 2023, with a trailing twelve-month (TTM) sales figure of ₹111 Cr. Quarterly sales figures indicate a recovery from the lows of FY 2023, with the latest quarter (Jun 2025) recording sales of ₹31.49 Cr. This represents a significant recovery from the ₹20.95 Cr reported in Jun 2022. However, sales growth has fluctuated, with quarterly sales peaking at ₹25.34 Cr in Dec 2024. The company’s operating profit margin (OPM) has improved from 0% in FY 2022 to 2.77% in FY 2025, indicating an overall positive trend in revenue generation, albeit at modest margins compared to industry peers.
Profitability and Efficiency Metrics
Profitability metrics for Frontline Corporation indicate a mixed performance. The net profit for FY 2023 stood at ₹3 Cr, a notable increase from ₹1 Cr in FY 2022, but the OPM has been relatively low, recording 2.51% in the latest quarter. The interest coverage ratio (ICR) is robust at 7.88x, suggesting the company can comfortably cover its interest obligations. However, the return on equity (ROE) at 14.6% is commendable, while the return on capital employed (ROCE) at 4.73% reflects the need for improved operational efficiency. The cash conversion cycle is reported at 60 days, which indicates the time taken to convert investments into cash flows. Despite the challenges, the improvement in net profit and operational efficiency reflects a positive trajectory, although the company still faces pressure to enhance its profit margins to align with industry standards.
Balance Sheet Strength and Financial Ratios
Frontline Corporation’s balance sheet reveals a total borrowing of ₹57 Cr against reserves of ₹10 Cr, indicating a high level of leverage with a total debt-to-equity ratio of 3.72x. While this level of debt can be seen as risky, the interest coverage ratio of 7.88x suggests that the company can manage its debt obligations effectively. The current ratio stands at 0.51, indicating potential liquidity issues, as values below 1 generally suggest that current liabilities exceed current assets. The book value per share rose to ₹30.92 in FY 2025, indicating a strengthening net worth. However, the company must address its liquidity concerns to ensure it can meet short-term obligations. The enterprise value to net operating revenue ratio of 0.73x indicates that the market values the company at a reasonable level relative to its operational performance.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Frontline Corporation reflects a stable structure, with promoters owning 47.57% of the company as of Jun 2025. The public holds 52.42%, indicating a broad base of retail investors. The number of shareholders has steadily increased from 870 in Sep 2022 to 1,378 in Jun 2025, demonstrating growing investor interest and confidence in the company’s potential. However, the absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) may suggest a lack of institutional backing, which could affect the stock’s stability and liquidity. The gradual decline in promoter stakes from 48.63% in Sep 2022 to 47.57% in Jun 2025 may also raise concerns about long-term commitment from major stakeholders. Nonetheless, the consistent increase in public ownership signals an optimistic sentiment among retail investors.
Outlook, Risks, and Final Insight
If margins sustain their current trajectory, Frontline Corporation could witness improved profitability, although the company faces several risks. The high debt levels may restrict financial flexibility, especially if market conditions worsen or interest rates rise. Additionally, the low current ratio suggests potential liquidity challenges that could impact operations. Furthermore, fluctuating sales growth and profit margins indicate a need for strategic operational improvements to enhance competitiveness. However, the company’s positive cash conversion cycle and strong interest coverage ratio provide a buffer against short-term financial pressures. Overall, while Frontline Corporation has shown resilience with improving sales and profitability metrics, addressing leverage and liquidity will be crucial for long-term growth and stability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Frontline Corporation Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Frontline Corporation Ltd | 21.0 Cr. | 42.0 | 61.5/37.4 | 6.84 | 30.8 | 0.00 % | 4.73 % | 14.6 % | 10.0 |
| Coastal Roadways Ltd | 16.3 Cr. | 39.2 | 45.6/29.0 | 10.2 | 56.4 | 0.00 % | 9.25 % | 6.35 % | 10.0 |
| Balurghat Technologies Ltd | 29.3 Cr. | 16.1 | 38.5/15.2 | 28.5 | 9.56 | 0.00 % | 13.0 % | 12.7 % | 10.0 |
| ABC India Ltd | 46.3 Cr. | 85.5 | 139/78.1 | 27.1 | 101 | 0.58 % | 6.57 % | 4.15 % | 10.0 |
| Transport Corporation of India Ltd (TCI) | 9,306 Cr. | 1,189 | 1,309/875 | 21.7 | 276 | 0.67 % | 20.5 % | 19.8 % | 2.00 |
| Industry Average | 3,331.00 Cr | 164.67 | 30.23 | 114.16 | 0.14% | 11.99% | 10.77% | 8.56 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20.95 | 15.56 | 19.60 | 20.56 | 22.84 | 21.27 | 21.18 | 22.56 | 24.86 | 25.26 | 25.34 | 28.50 | 31.49 |
| Expenses | 20.73 | 15.00 | 18.64 | 21.48 | 22.82 | 20.94 | 21.02 | 23.02 | 24.43 | 24.58 | 24.56 | 28.14 | 30.70 |
| Operating Profit | 0.22 | 0.56 | 0.96 | -0.92 | 0.02 | 0.33 | 0.16 | -0.46 | 0.43 | 0.68 | 0.78 | 0.36 | 0.79 |
| OPM % | 1.05% | 3.60% | 4.90% | -4.47% | 0.09% | 1.55% | 0.76% | -2.04% | 1.73% | 2.69% | 3.08% | 1.26% | 2.51% |
| Other Income | 0.76 | 0.70 | 0.73 | 2.22 | 0.73 | 0.79 | 0.87 | 0.96 | 0.78 | 1.07 | 0.81 | 1.70 | 0.73 |
| Interest | 0.01 | 0.01 | 0.01 | 0.08 | 0.01 | 0.01 | 0.02 | 0.18 | 0.21 | 0.20 | 0.18 | 0.25 | 0.22 |
| Depreciation | 0.38 | 0.39 | 0.41 | 0.42 | 0.42 | 0.42 | 0.38 | 0.38 | 0.47 | 0.49 | 0.49 | 0.74 | 0.56 |
| Profit before tax | 0.59 | 0.86 | 1.27 | 0.80 | 0.32 | 0.69 | 0.63 | -0.06 | 0.53 | 1.06 | 0.92 | 1.07 | 0.74 |
| Tax % | 25.42% | 23.26% | 24.41% | 21.25% | 59.38% | 37.68% | 34.92% | -533.33% | 28.30% | 13.21% | 23.91% | 17.76% | 22.97% |
| Net Profit | 0.44 | 0.67 | 0.97 | 0.63 | 0.14 | 0.42 | 0.41 | 0.25 | 0.39 | 0.91 | 0.71 | 0.88 | 0.57 |
| EPS in Rs | 0.88 | 1.34 | 1.94 | 1.26 | 0.28 | 0.84 | 0.82 | 0.50 | 0.78 | 1.82 | 1.42 | 1.76 | 1.14 |
Last Updated: August 19, 2025, 3:10 pm
Below is a detailed analysis of the quarterly data for Frontline Corporation Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 31.49 Cr.. The value appears strong and on an upward trend. It has increased from 28.50 Cr. (Mar 2025) to 31.49 Cr., marking an increase of 2.99 Cr..
- For Expenses, as of Jun 2025, the value is 30.70 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.14 Cr. (Mar 2025) to 30.70 Cr., marking an increase of 2.56 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.79 Cr.. The value appears strong and on an upward trend. It has increased from 0.36 Cr. (Mar 2025) to 0.79 Cr., marking an increase of 0.43 Cr..
- For OPM %, as of Jun 2025, the value is 2.51%. The value appears strong and on an upward trend. It has increased from 1.26% (Mar 2025) to 2.51%, marking an increase of 1.25%.
- For Other Income, as of Jun 2025, the value is 0.73 Cr.. The value appears to be declining and may need further review. It has decreased from 1.70 Cr. (Mar 2025) to 0.73 Cr., marking a decrease of 0.97 Cr..
- For Interest, as of Jun 2025, the value is 0.22 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.25 Cr. (Mar 2025) to 0.22 Cr., marking a decrease of 0.03 Cr..
- For Depreciation, as of Jun 2025, the value is 0.56 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.74 Cr. (Mar 2025) to 0.56 Cr., marking a decrease of 0.18 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.74 Cr.. The value appears to be declining and may need further review. It has decreased from 1.07 Cr. (Mar 2025) to 0.74 Cr., marking a decrease of 0.33 Cr..
- For Tax %, as of Jun 2025, the value is 22.97%. The value appears to be increasing, which may not be favorable. It has increased from 17.76% (Mar 2025) to 22.97%, marking an increase of 5.21%.
- For Net Profit, as of Jun 2025, the value is 0.57 Cr.. The value appears to be declining and may need further review. It has decreased from 0.88 Cr. (Mar 2025) to 0.57 Cr., marking a decrease of 0.31 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.14. The value appears to be declining and may need further review. It has decreased from 1.76 (Mar 2025) to 1.14, marking a decrease of 0.62.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:20 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42 | 38 | 38 | 43 | 44 | 47 | 48 | 59 | 72 | 77 | 88 | 104 | 111 |
| Expenses | 40 | 36 | 38 | 46 | 44 | 47 | 50 | 58 | 71 | 76 | 88 | 102 | 108 |
| Operating Profit | 2 | 1 | 0 | -2 | -0 | -1 | -2 | 1 | 0 | 1 | 0 | 2 | 3 |
| OPM % | 5% | 3% | 1% | -5% | -0% | -1% | -4% | 1% | 0% | 1% | 0% | 2% | 2% |
| Other Income | 4 | 3 | 1 | 10 | 4 | 3 | 3 | 3 | 4 | 4 | 3 | 4 | 4 |
| Interest | 6 | 5 | 5 | 5 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
| Depreciation | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | -1 | -2 | -5 | 1 | 2 | -1 | -1 | 1 | 2 | 4 | 2 | 4 | 4 |
| Tax % | -87% | -11% | -18% | 33% | 17% | -35% | -16% | 12% | 21% | 23% | 22% | 19% | |
| Net Profit | -0 | -2 | -4 | 1 | 2 | -0 | -1 | 1 | 1 | 3 | 1 | 3 | 3 |
| EPS in Rs | -0.34 | -3.66 | -8.50 | 1.70 | 3.84 | -0.66 | -1.98 | 2.30 | 2.90 | 5.42 | 2.44 | 5.78 | 6.14 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -100.00% | 125.00% | 100.00% | -100.00% | 200.00% | 0.00% | 200.00% | -66.67% | 200.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 225.00% | -25.00% | -200.00% | 300.00% | -200.00% | 200.00% | -266.67% | 266.67% |
Frontline Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 16% |
| 3 Years: | 13% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 32% |
| 3 Years: | 12% |
| TTM: | 109% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 34% |
| 3 Years: | 40% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 15% |
| 3 Years: | 14% |
| Last Year: | 15% |
Last Updated: September 5, 2025, 3:30 pm
Balance Sheet
Last Updated: July 25, 2025, 1:17 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 7 | 5 | 1 | 0 | 2 | 2 | 1 | 2 | 4 | 6 | 8 | 10 |
| Borrowings | 38 | 45 | 39 | 51 | 54 | 53 | 53 | 52 | 49 | 49 | 57 | 57 |
| Other Liabilities | 24 | 19 | 32 | 17 | 15 | 15 | 10 | 6 | 6 | 6 | 8 | 9 |
| Total Liabilities | 74 | 73 | 77 | 73 | 77 | 75 | 68 | 65 | 63 | 66 | 77 | 82 |
| Fixed Assets | 27 | 26 | 28 | 32 | 35 | 33 | 34 | 32 | 31 | 30 | 34 | 35 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 |
| Investments | 7 | 7 | 7 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 0 |
| Other Assets | 40 | 40 | 42 | 40 | 41 | 41 | 35 | 32 | 32 | 34 | 40 | 46 |
| Total Assets | 74 | 73 | 77 | 73 | 77 | 75 | 68 | 65 | 63 | 66 | 77 | 82 |
Below is a detailed analysis of the balance sheet data for Frontline Corporation Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
- For Reserves, as of Mar 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 10.00 Cr., marking an increase of 2.00 Cr..
- For Borrowings, as of Mar 2025, the value is 57.00 Cr.. The value remains steady. However, Borrowings exceed Reserves, which may signal higher financial risk. There is no change compared to the previous period (Mar 2024) which recorded 57.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Mar 2024) to 9.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 82.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 77.00 Cr. (Mar 2024) to 82.00 Cr., marking an increase of 5.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 35.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Mar 2024) to 35.00 Cr., marking an increase of 1.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 2.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Other Assets, as of Mar 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Mar 2024) to 46.00 Cr., marking an increase of 6.00 Cr..
- For Total Assets, as of Mar 2025, the value is 82.00 Cr.. The value appears strong and on an upward trend. It has increased from 77.00 Cr. (Mar 2024) to 82.00 Cr., marking an increase of 5.00 Cr..
However, the Borrowings (57.00 Cr.) are higher than the Reserves (10.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -36.00 | -44.00 | -39.00 | -53.00 | -54.00 | -54.00 | -55.00 | -51.00 | -49.00 | -48.00 | -57.00 | -55.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 74 | 66 | 77 | 82 | 66 | 57 | 57 | 42 | 39 | 38 | 39 |
| Inventory Days | 169 | 213 | 208 | 130 | 141 | 142 | 88 | 40 | 35 | 47 | 48 | 53 |
| Days Payable | 242 | 200 | 64 | 203 | 216 | 192 | 100 | 38 | 24 | 24 | 28 | 32 |
| Cash Conversion Cycle | 1 | 86 | 209 | 4 | 7 | 16 | 45 | 59 | 53 | 61 | 59 | 60 |
| Working Capital Days | -291 | -365 | -348 | -273 | -246 | -237 | -252 | -204 | -161 | -147 | -136 | -108 |
| ROCE % | 4% | 5% | 0% | 11% | 4% | -0% | -1% | 3% | 4% | 4% | 2% | 5% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 5.80 | 2.44 | 5.44 | 2.91 | 2.30 |
| Diluted EPS (Rs.) | 5.80 | 2.44 | 5.44 | 2.91 | 2.30 |
| Cash EPS (Rs.) | 10.21 | 5.67 | 8.65 | 6.43 | 6.34 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 30.92 | 25.11 | 22.77 | 17.25 | 14.36 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 30.92 | 25.11 | 22.77 | 17.25 | 14.36 |
| Revenue From Operations / Share (Rs.) | 208.85 | 176.49 | 154.04 | 144.14 | 117.74 |
| PBDIT / Share (Rs.) | 13.28 | 6.83 | 10.51 | 7.78 | 7.51 |
| PBIT / Share (Rs.) | 8.87 | 3.59 | 7.30 | 4.26 | 3.47 |
| PBT / Share (Rs.) | 7.18 | 3.15 | 7.09 | 3.70 | 2.62 |
| Net Profit / Share (Rs.) | 5.80 | 2.44 | 5.44 | 2.91 | 2.30 |
| PBDIT Margin (%) | 6.35 | 3.86 | 6.82 | 5.39 | 6.37 |
| PBIT Margin (%) | 4.24 | 2.03 | 4.74 | 2.95 | 2.94 |
| PBT Margin (%) | 3.44 | 1.78 | 4.59 | 2.56 | 2.22 |
| Net Profit Margin (%) | 2.77 | 1.38 | 3.53 | 2.02 | 1.95 |
| Return on Networth / Equity (%) | 18.77 | 9.72 | 23.90 | 16.88 | 16.04 |
| Return on Capital Employeed (%) | 19.51 | 8.43 | 29.19 | 23.00 | 17.80 |
| Return On Assets (%) | 3.52 | 1.57 | 4.07 | 2.28 | 1.77 |
| Long Term Debt / Equity (X) | 0.47 | 0.69 | 0.09 | 0.07 | 0.35 |
| Total Debt / Equity (X) | 3.72 | 4.56 | 4.34 | 5.69 | 7.08 |
| Asset Turnover Ratio (%) | 1.31 | 1.22 | 1.18 | 1.12 | 0.88 |
| Current Ratio (X) | 0.51 | 0.54 | 0.48 | 0.44 | 0.44 |
| Quick Ratio (X) | 0.33 | 0.38 | 0.35 | 0.35 | 0.36 |
| Inventory Turnover Ratio (X) | 10.79 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 7.88 | 15.24 | 48.34 | 13.75 | 8.86 |
| Interest Coverage Ratio (Post Tax) (X) | 4.44 | 6.45 | 26.04 | 6.15 | 3.72 |
| Enterprise Value (Cr.) | 76.12 | 75.35 | 60.46 | 61.41 | 54.17 |
| EV / Net Operating Revenue (X) | 0.73 | 0.85 | 0.78 | 0.85 | 0.92 |
| EV / EBITDA (X) | 11.52 | 22.18 | 11.56 | 15.87 | 14.49 |
| MarketCap / Net Operating Revenue (X) | 0.19 | 0.21 | 0.15 | 0.18 | 0.08 |
| Price / BV (X) | 1.33 | 1.55 | 1.07 | 1.57 | 0.67 |
| Price / Net Operating Revenue (X) | 0.19 | 0.21 | 0.15 | 0.18 | 0.08 |
| EarningsYield | 0.14 | 0.06 | 0.22 | 0.10 | 0.23 |
After reviewing the key financial ratios for Frontline Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.80. This value is within the healthy range. It has increased from 2.44 (Mar 24) to 5.80, marking an increase of 3.36.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.80. This value is within the healthy range. It has increased from 2.44 (Mar 24) to 5.80, marking an increase of 3.36.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.21. This value is within the healthy range. It has increased from 5.67 (Mar 24) to 10.21, marking an increase of 4.54.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.92. It has increased from 25.11 (Mar 24) to 30.92, marking an increase of 5.81.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.92. It has increased from 25.11 (Mar 24) to 30.92, marking an increase of 5.81.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 208.85. It has increased from 176.49 (Mar 24) to 208.85, marking an increase of 32.36.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 13.28. This value is within the healthy range. It has increased from 6.83 (Mar 24) to 13.28, marking an increase of 6.45.
- For PBIT / Share (Rs.), as of Mar 25, the value is 8.87. This value is within the healthy range. It has increased from 3.59 (Mar 24) to 8.87, marking an increase of 5.28.
- For PBT / Share (Rs.), as of Mar 25, the value is 7.18. This value is within the healthy range. It has increased from 3.15 (Mar 24) to 7.18, marking an increase of 4.03.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.80. This value is within the healthy range. It has increased from 2.44 (Mar 24) to 5.80, marking an increase of 3.36.
- For PBDIT Margin (%), as of Mar 25, the value is 6.35. This value is below the healthy minimum of 10. It has increased from 3.86 (Mar 24) to 6.35, marking an increase of 2.49.
- For PBIT Margin (%), as of Mar 25, the value is 4.24. This value is below the healthy minimum of 10. It has increased from 2.03 (Mar 24) to 4.24, marking an increase of 2.21.
- For PBT Margin (%), as of Mar 25, the value is 3.44. This value is below the healthy minimum of 10. It has increased from 1.78 (Mar 24) to 3.44, marking an increase of 1.66.
- For Net Profit Margin (%), as of Mar 25, the value is 2.77. This value is below the healthy minimum of 5. It has increased from 1.38 (Mar 24) to 2.77, marking an increase of 1.39.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.77. This value is within the healthy range. It has increased from 9.72 (Mar 24) to 18.77, marking an increase of 9.05.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.51. This value is within the healthy range. It has increased from 8.43 (Mar 24) to 19.51, marking an increase of 11.08.
- For Return On Assets (%), as of Mar 25, the value is 3.52. This value is below the healthy minimum of 5. It has increased from 1.57 (Mar 24) to 3.52, marking an increase of 1.95.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.47. This value is within the healthy range. It has decreased from 0.69 (Mar 24) to 0.47, marking a decrease of 0.22.
- For Total Debt / Equity (X), as of Mar 25, the value is 3.72. This value exceeds the healthy maximum of 1. It has decreased from 4.56 (Mar 24) to 3.72, marking a decrease of 0.84.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.31. It has increased from 1.22 (Mar 24) to 1.31, marking an increase of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1.5. It has decreased from 0.54 (Mar 24) to 0.51, marking a decrease of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 1. It has decreased from 0.38 (Mar 24) to 0.33, marking a decrease of 0.05.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 10.79. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 10.79, marking an increase of 10.79.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.88. This value is within the healthy range. It has decreased from 15.24 (Mar 24) to 7.88, marking a decrease of 7.36.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.44. This value is within the healthy range. It has decreased from 6.45 (Mar 24) to 4.44, marking a decrease of 2.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 76.12. It has increased from 75.35 (Mar 24) to 76.12, marking an increase of 0.77.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 24) to 0.73, marking a decrease of 0.12.
- For EV / EBITDA (X), as of Mar 25, the value is 11.52. This value is within the healthy range. It has decreased from 22.18 (Mar 24) to 11.52, marking a decrease of 10.66.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 1. It has decreased from 0.21 (Mar 24) to 0.19, marking a decrease of 0.02.
- For Price / BV (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has decreased from 1.55 (Mar 24) to 1.33, marking a decrease of 0.22.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 1. It has decreased from 0.21 (Mar 24) to 0.19, marking a decrease of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.14. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.14, marking an increase of 0.08.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Frontline Corporation Ltd:
- Net Profit Margin: 2.77%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.51% (Industry Average ROCE: 11.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.77% (Industry Average ROE: 10.77%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.44
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 6.84 (Industry average Stock P/E: 30.23)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.72
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.77%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Transport - Road | 4, B.B.D Bag (East), Stephen House, Kolkata West Bengal 700001 | frontlinecorplimited@gmail.com http://www.frontlinecorporation.org |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ram Prasad Agarwal | Chairman & Director |
| Mr. Pawan Kumar Agarwal | Managing Director |
| Mr. Narayan Prasad Agarwal | Director |
| Mr. Saurabh Jhunjhunwala | Director |
| Mrs. Dipika Pradeep Soni | Independent Woman Director |
| Mr. Dipen Ashit Dalal | Independent Director |
| Ms. Aarefa Kutub Kapasi | Independent Woman Director |
| Mrs. Ummay Amen Mashraqi | Independent Woman Director |
FAQ
What is the intrinsic value of Frontline Corporation Ltd?
Frontline Corporation Ltd's intrinsic value (as of 18 October 2025) is 25.10 which is 40.24% lower the current market price of 42.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 21.0 Cr. market cap, FY2025-2026 high/low of 61.5/37.4, reserves of ₹10 Cr, and liabilities of 82 Cr.
What is the Market Cap of Frontline Corporation Ltd?
The Market Cap of Frontline Corporation Ltd is 21.0 Cr..
What is the current Stock Price of Frontline Corporation Ltd as on 18 October 2025?
The current stock price of Frontline Corporation Ltd as on 18 October 2025 is 42.0.
What is the High / Low of Frontline Corporation Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Frontline Corporation Ltd stocks is 61.5/37.4.
What is the Stock P/E of Frontline Corporation Ltd?
The Stock P/E of Frontline Corporation Ltd is 6.84.
What is the Book Value of Frontline Corporation Ltd?
The Book Value of Frontline Corporation Ltd is 30.8.
What is the Dividend Yield of Frontline Corporation Ltd?
The Dividend Yield of Frontline Corporation Ltd is 0.00 %.
What is the ROCE of Frontline Corporation Ltd?
The ROCE of Frontline Corporation Ltd is 4.73 %.
What is the ROE of Frontline Corporation Ltd?
The ROE of Frontline Corporation Ltd is 14.6 %.
What is the Face Value of Frontline Corporation Ltd?
The Face Value of Frontline Corporation Ltd is 10.0.